A Real Conversation, About Real Patients: Redo Aortic Valve Replacements

A Real Conversation, About Real Patients: Redo Aortic Valve Replacements
Originally Broadcast: Thursday, June 10, 2021 at 7:00 PM ET

Aortic valve management during the lifetime of a patient depends on how long and how well the patient would live. Today, there are two primary options for aortic valve disease management - multiple surgeries or anticoagulation therapy. Join our live discussion with renowned cardiologists and cardiac surgeons and let’s talk about real patient cases and the factors that determine your strategy for a lifetime of valve management for your AVR patients.




The views expressed during this presentation are the speaker’s own and do not necessarily reflect those of CryoLife, the speaker’s employer, organization, committee or other group or individual.  Unattributed data, device selection, and procedural guidance is a matter of physician preference are presented on the basis of the individual speaker’s observations and experiences and should be treated accordingly. Federal law restricts the devices discussed herein to sale by or on the order of a physician. Refer to the Instructions for Use and other product insert documentation that accompanies each of these devices for indications, contraindications, warnings, precautions, possible complications, and instructions for use.  

On-X® Prosthetic Heart Valves IFU’s

Products not available in all markets.  The content of this presentation, including any copyrightable content included herein, is used with permission from the speaker.

On-X Life Technologies, Inc. is a wholly owned subsidiary of CryoLife, Inc. The On-X® Prosthetic Heart Valves are manufactured by On-X Life Technologies, Inc. The snowflake design, CryoLife, Life Restoring Technologies, and On-X are registered trademarks owned by CryoLife, Inc. or its subsidiaries. All other registered trademarks are owned by their respective owners. © 2021 CryoLife, Inc. All rights reserved.

Created by